StreetAlpha.app
Home › Stocks › CTSO

Cytosorbents Corp (CTSO)

$4.52
▼ −6.80%
LAST CLOSE · NOV 17

CytoSorbents makes blood purification cartridges that remove toxins and inflammatory substances from blood for hospitals and veterinary clinics. It last closed at $4.52 on Nov 17, down 6.80% on the day.

AI Auto Pilots
Is CTSO in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$37.2M
+3.1% vs a year ago
Net income
−$18.2M
−48.9% margin
EPS (diluted)
−$0.29
Free cash flow
−$9.3M
−25.0% margin
Valuation
Market cap
$284.0M
62.8M shares
P/E
–
No P/E while losing money
Price to sales
7.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$4.4M
At Jun 30
Debt
$17.2M
At Jun 30
Shareholder equity
−$751K
Shares outstanding
62.8M
At Jul 31
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $43.2M$43.2MFY2021FY2022: $34.7M$34.7MFY2022FY2023: $31.1M$31.1MFY2023FY2024: $35.6M$35.6MFY2024FY2025: $37.1M$37.1MFY2025

From CTSO's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Aug 6). Last 12 months adds up the four latest quarters.

Last report
Nov 12
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated CTSO in the past 90 days, not enough for a consensus
Average 12-month target
$9.50
▲ 110.2% upside

Based on 1 analyst who set a price target on CTSO in the past 90 days. The average target is $9.50, with a high of $9.50 and a low of $9.50, compared with the last close of $4.52.

Low $9.50Avg $9.50High $9.50
Blue marker: last close $4.52
Highest target$9.50
Average target$9.50
Lowest target$9.50
Latest rating changes
WBB SecuritiesInitiated
Oct 21Buy$9.50
DateFirmActionRatingPrice target
Oct 21WBB SecuritiesInitiatedBuy$9.50
Loading…

Technical Analysis

CTSO · as of the Nov 17 close · updated after every close
Downtrend

The stock is 10% below its 20 day and 6% below its 50 day average. It is 99% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 46). The nearest support is the swing low (Oct 26) at $4.10, and the nearest resistance the Pivot at $4.76.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 15.4%/day
Key levels
$17.0052 week high+276.1%
$8.98200 day average+98.7%
$6.24Swing high (Nov 10)+38.1%
$6.09100 day average+34.7%
$5.32Pivot R1+17.7%
$4.9920 day average+10.4%
$4.7950 day average+6.0%
$4.76Pivot+5.3%
$4.52Last close
$4.10Swing low (Oct 26)−9.3%
$3.96Pivot S1−12.4%
$2.8452 week low−37.2%
Indicators
RSI (14)45.51Middle of its rangeNeutral
MACD0.07Below its signal lineBearish
Stochastic32.7Middle of its rangeNeutral
ADX (14)19.7No clear trend
Williams %R-77.5Oversold below −80, overbought above −20Neutral
CCI (20)-40.5Oversold below −100, overbought above 100Neutral
Rate of change−0.4%Change over 10 sessionsBearish
ATR (14)$0.70Typical daily range, 15.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CTSO

What happened before

See how CTSO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow CTSO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CTSO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in CTSO in the last 90 days.

Loading…

See today’s whale options flow across the market →

CTSO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼27 buying vs 51 selling
  • ▼Held by funds -24.6 pts
  • ▼Funds holding -22
  • ▼Superinvestors: 0 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2951−43.1%
In funds' top 1000–
Held by funds1.1%25.7%−24.6 pts
New / increased27 / 07 / 11+50.0%
Reduced / sold out2 / 4912 / 7+168.4%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CTSO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CTSO is in one of them and how their past CTSO trades turned out.

CTSO in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CTSO in an article yet. Here's the latest on the wider market.

About Cytosorbents

CytoSorbents is a medical device company based in Princeton, New Jersey. It makes blood purification cartridges filled with porous polymer beads that remove harmful substances from blood. Its main product, CytoSorb, is sold to hospitals for use in intensive care and cardiac surgery, where it connects to blood pumps already in use. The company also sells products for emergency care in animals and is seeking U.S. approval for a device that removes certain blood thinners during heart surgery.

Headquarters
Princeton, NJ